203 related articles for article (PubMed ID: 11901456)
21. Emerging therapies for rectal cancer.
Chua YJ; Cunningham D
Colorectal Dis; 2006 Sep; 8 Suppl 3():18-20. PubMed ID: 16813587
[TBL] [Abstract][Full Text] [Related]
22. [Preoperative radiotherapy of cancer of the rectum. What if Europe is right?].
Gérard JP; Reibel S; François Y; Bosset JF; Horiot JC
Rev Prat; 1999 Feb; 49(3):237-9. PubMed ID: 10189789
[No Abstract] [Full Text] [Related]
23. Economics of preoperative radiotherapy with total mesorectal excision: what can we learn from the Dutch experience?
Simunovic M; Gafni A; Levine M
J Clin Oncol; 2004 Jan; 22(2):217-9. PubMed ID: 14665616
[No Abstract] [Full Text] [Related]
24. [Rectal cancer margin].
Rivoire M; Malerba M; Gandini A
Bull Cancer; 2008 Dec; 95(12):1177-81. PubMed ID: 19091651
[TBL] [Abstract][Full Text] [Related]
25. Impact of time duration after neoadjuvant therapy to surgery on response and outcome in rectal cancer patients.
Willett CG; Czito BG
Ann Surg Oncol; 2008 Oct; 15(10):2636-8. PubMed ID: 18663534
[No Abstract] [Full Text] [Related]
26. The multidisciplinary management of rectal cancer.
Meredith KL; Hoffe SE; Shibata D
Surg Clin North Am; 2009 Feb; 89(1):177-215, ix-x. PubMed ID: 19186236
[TBL] [Abstract][Full Text] [Related]
27. Cost-utility analysis of preoperative radiotherapy in patients with rectal cancer undergoing total mesorectal excision: a study of the Dutch Colorectal Cancer Group.
Van Den Brink M; Van Den Hout WB; Stiggelbout AM; Klein Kranenbarg E; Marijnen CA; Van De Velde CJ; Kievit J;
J Clin Oncol; 2004 Jan; 22(2):244-53. PubMed ID: 14665610
[TBL] [Abstract][Full Text] [Related]
28. Rectal cancer: progress over the past two decades.
Tulchinsky H; Rabau M
Isr Med Assoc J; 2006 Oct; 8(10):711-2. PubMed ID: 17125121
[No Abstract] [Full Text] [Related]
29. Multidisciplinary treatment of resectable rectal cancer.
Ayala DN; Russo SM; Blackstock AW
Expert Rev Gastroenterol Hepatol; 2009 Aug; 3(4):383-94. PubMed ID: 19673625
[TBL] [Abstract][Full Text] [Related]
30. [Importance of neoadjuvant chemotherapy in gastrointestinal tumors. A new standard?].
Moosmann N; Boeck S; Heinemann V
Med Klin (Munich); 2007 Jul; 102(7):551-62; quiz 563-4. PubMed ID: 17634873
[No Abstract] [Full Text] [Related]
31. Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy.
Bouzourene H; Bosman FT; Seelentag W; Matter M; Coucke P
Cancer; 2002 Feb; 94(4):1121-30. PubMed ID: 11920483
[TBL] [Abstract][Full Text] [Related]
32. Preoperative radiation therapy for upper rectal cancer T3,T4/Nx: selectivity essential.
Popek S; Tsikitis VL; Hazard L; Cohen AM
Clin Colorectal Cancer; 2012 Jun; 11(2):88-92. PubMed ID: 22154165
[TBL] [Abstract][Full Text] [Related]
33. Total mesorectal excision and management of rectal cancer.
Pinsk I; Phang PT
Expert Rev Anticancer Ther; 2007 Oct; 7(10):1395-403. PubMed ID: 17944565
[TBL] [Abstract][Full Text] [Related]
34. Prognostic markers of local relapse in rectal cancer: are we any further forward?
Johnston PG
J Clin Oncol; 2006 Sep; 24(25):4049-50. PubMed ID: 16943520
[No Abstract] [Full Text] [Related]
35. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.
Peeters KC; Marijnen CA; Nagtegaal ID; Kranenbarg EK; Putter H; Wiggers T; Rutten H; Pahlman L; Glimelius B; Leer JW; van de Velde CJ;
Ann Surg; 2007 Nov; 246(5):693-701. PubMed ID: 17968156
[TBL] [Abstract][Full Text] [Related]
36. Combined modality therapy of resectable rectal cancer: current approaches.
Minsky BD
Tech Coloproctol; 2004 Aug; 8(2):67-76. PubMed ID: 15309641
[TBL] [Abstract][Full Text] [Related]
37. The clinical significance of the circumferential resection margin following preoperative pelvic chemo-radiotherapy in rectal cancer: why we need a common language.
Glynne-Jones R; Mawdsley S; Novell JR
Colorectal Dis; 2006 Nov; 8(9):800-7. PubMed ID: 17032329
[TBL] [Abstract][Full Text] [Related]
38. Contact X-ray therapy for rectal cancer: experience in Centre Antoine-Lacassagne, Nice, 2002-2006.
Gérard JP; Ortholan C; Benezery K; Ginot A; Hannoun-Levi JM; Chamorey E; Benchimol D; François E
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):665-70. PubMed ID: 18455327
[TBL] [Abstract][Full Text] [Related]
39. Harm and benefits of short-term pre-operative radiotherapy in patients with resectable rectal carcinomas.
Bakx R; Emous M; Legemate DA; Zoetmulder FA; van Tienhoven G; Bemelman WA; van Lanschot JJ
Eur J Surg Oncol; 2006 Jun; 32(5):520-6. PubMed ID: 16600560
[TBL] [Abstract][Full Text] [Related]
40. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
Thomschke D; Kyau-Ummen B; Halbfass HJ
Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
